ICH announces Q&A Document on Q11 Guideline – Main Focus: API Starting Materials

Posted on

New Drug Approvals

The ICH has recently published a Business Plan and a Concept Paper on the elaboration of a Q&A document on the ICH Q11 Guideline. Read more here.

http://www.gmp-compliance.org/enews_4631_ICH-announces-Q-A-Document-on-Q11-Guideline—Main-Focus-API-Starting-Materials_9246,S-WKS_n.html

ICH announces Q&A Document on Q11 Guideline – Main Focus: API Starting Materials

The ICH Q11 Guideline entitled “Development and Manufacture of Drug Substances” from May 2012 has been implemented in the three ICH regions EU, USA and Japan for 2 years now. It describes the approach to developing APIs based on an in-depth understanding of the manufacturing process and adequate strategies to control this process. The document indicates what information should be provided about the quality of the API in Module 3 of the CTD (Common Technical Document) within the framework of a marketing authorisation application.

In the meantime, there has been an accumulation of cases where the applicant and the regulatory authorities adopted different positions with regard to…

View original post 344 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s